Back
Summit Therapeutics Stock Price Chart
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
SMMT
Summit Therapeutics
Last Price:
19.72
Seasonality Move:
33.87%
7 Day Trial
ALL ACCESS PASS
$
7
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- The current trend is relatively stagnant and SMMT is experiencing slight selling pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.23 | Sell |
| 20-day SMA: | 23.16 | Sell |
| 50-day SMA: | 16.44 | Buy |
| 200-day SMA: | 7.96 | Buy |
| 8-day EMA: | 20.12 | Sell |
| 20-day EMA: | 20.48 | Sell |
| 50-day EMA: | 17.38 | Buy |
| 200-day EMA: | 9.8 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.66 | Buy |
| Relative Strength Index (14 RSI): | 47.31 | Sell |
| Chaikin Money Flow: | -209908 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.25 - 26.29) | Sell |
| Bollinger Bands (100): | (5.69 - 18.35) | Buy |
Summit Therapeutics Technical Analysis
| Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | Oct 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 18.92 while SMMT 8-day simple moving average is 20.23, which is a Sell signal.
- The stock price of SMMT is 18.92 while Summit Therapeutics 20-day SMA is 23.16, which makes it a Sell.
- Summit Therapeutics 50-day simple moving average is 16.44 while SMMT share price is 18.92, making it a Buy technically.
- SMMT stock price is 18.92 and Summit Therapeutics 200-day simple moving average is 7.96, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
44
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Sell
The current Summit Therapeutics [SMMT] share price is $18.92. The Score for SMMT is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics Stock Info
Market Cap:
13.9B
Price in USD:
18.92
Share Volume:
2.45M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.64
Sell
44
Summit Therapeutics (SMMT)
is a Sell
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 18.92 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 18.92 while SMMT 8-day exponential moving average is 20.12, which is a Sell signal.
- The stock price of SMMT is 18.92 while Summit Therapeutics 20-day EMA is 20.48, which makes it a Sell.
- Summit Therapeutics 50-day exponential moving average is 17.38 while SMMT share price is 18.92, making it a Buy technically.
- SMMT stock price is 18.92 and Summit Therapeutics 200-day simple moving average is 9.80, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is 0.66, suggesting Summit Therapeutics is a Buy
- Summit Therapeutics Relative Strength Index (RSI) is 47.31, which suggest Summit Therapeutics is oversold
- The Bollinger Bands (25) for Summit Therapeutics is (16.25 - 26.29), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (5.69 - 18.35), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.